Where Anti-CHRM3 (muscarinic M3) is reported
Also listed as: GPCR autoantibody
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| PACVS | ↕ inconsistent | healthy controls | Autonomic, GI symptoms | Mantovani et al. 2024 |
Frequently asked questions
In which conditions is Anti-CHRM3 (muscarinic M3) altered?
In the OSMF atlas Anti-CHRM3 (muscarinic M3) is reported in PACVS. It is mixed in 1 across 1 entries.
Is there a standard clinical test for Anti-CHRM3 (muscarinic M3)?
The atlas entries for Anti-CHRM3 (muscarinic M3) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal Anti-CHRM3 (muscarinic M3) result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-30 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.